PPD is the ideal consulting partner to assist with your biopharmaceutical product’s success from preclinical through post-approval.
Expertise in nearly 40 psychiatric and neurological disorders, and clinically trained neuroscience teams led by scientists and clinicians with extensive neuroscience experience.
PPD's Phase I clinic in Austin, Texas, conducts clinical studies to determine how new medicines act in the bodies of healthy volunteers. This is not testing to determine if the medicine works.
View all of PPD's news releases.
A report on the expansion of the PPD® Laboratories vaccine sciences lab in Richmond, Virginia, as reported in Outsourcing-Pharma.
Outsourcing Pharma (May 2017)
Outsourcing-Pharma reports on the introduction of Acurian Consulting Services.
CenterWatch reports on the combining of PPD’s medical affairs operations team and Evidera.
CenterWatch Weekly (May 2017)
FierceBiotech reports on combination of PPD’s medical affairs research operations and Evidera.
FierceBiotech (May 2017)
Outsourcing-Pharma reports on combination of PPD’s medical affairs research operations and Evidera.
Outsourcing-Pharma provides insight into PPD's recapitalization.
Oursourcing Pharma (May 2017)
PPD's David Johnston comments on the new operational, organizational and partnership-based approaches to drug development.
Contract Pharma (May 2017)
Elizabeth Madichie, Alistair Davidson, Denise Moody and Vincenzo Cannizzaro explain how a one-team model forges an outsourcing partnership to deliver efficient global regulatory lifecycle management.
Horacio Plotkin takes part in a discussion on the factors that impact the recruiting of patients for rare disease trials.
PharmaVOICE (May 2017)
PPD’s recapitalization covered in FierceBiotech.
FierceBiotech (April 2017)
We want to hear from you
Register in PPD's Database
© 2017 Pharmaceutical Product Development, LLC. All rights reserved.